FDA inspection

Ivax Pharmaceuticals Inc: FDA inspection ending Nov 29, 2001

FDA inspection 197528 · Voluntary Action Indicated (VAI) · Northvale, NJ

Key facts

Inspection ID 197528
Firm Ivax Pharmaceuticals Inc
FEI number 2219541
Address 140 Legrand Ave
City Northvale
State NJ
ZIP 07647-2403
Fiscal year 2002
Inspection end date Nov 29, 2001
Classification Voluntary Action Indicated (VAI)
Project area Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation|Drug Quality Assurance|Generic Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • Yes Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections